{"transactions":[{"id":759067,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T21:00:26.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock units (\"RSUs\") awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date."}],"balance_after":161054,"source":{"system":"sec-edgar","filing":"0001104659-26-068335","document":"tm2615354-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465926068335/tm2615354-1_4seq1.xml","form_type":"4"}},{"id":1315833,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T22:30:11.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":30666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock units (\"RSUs\") awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024."}],"balance_after":41054,"source":{"system":"sec-edgar","filing":"0001104659-25-000885","document":"tm251864-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465925000885/tm251864-1_4seq1.xml","form_type":"4"}},{"id":2468045,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-17T22:00:38.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":25333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on January 15, 2022 until fully vested and exercisable on the 12 month anniversary of December 15, 2021."}],"balance_after":25333,"derivative":{"exercise_price":0.75,"expiration_date":"2031-12-15","underlying":"Common Stock","underlying_shares":25333},"source":{"system":"sec-edgar","filing":"0001104659-21-151209","document":"tm2135659-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921151209/tm2135659-1_4seq1.xml","form_type":"4"}},{"id":2477586,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-11T01:02:58.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":25333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the Company's 2020 Annual Meeting of Stockholders, pursuant to the Company's Second Amended and Restated Director Compensation Plan, as amended, option vested and became exercisable in 12 consecutive, equal monthly installments commencing on December 11, 2020 until fully vested and exercisable on the 12 month anniversary of November 11, 2020, provided that the Reporting Person remained a member of the Board of Directors of the Issuer on each vesting date."}],"balance_after":25333,"derivative":{"exercise_price":0.75,"expiration_date":"2031-12-10","underlying":"Common Stock","underlying_shares":25333},"source":{"system":"sec-edgar","filing":"0001104659-21-148750","document":"tm2135032-5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921148750/tm2135032-5_4.xml","form_type":"4"}},{"id":3271035,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-14T22:00:26.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":25333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on January 12, 2020 until fully vested and exercisable on December 12, 2020, provided that the reporting person remains a director (and committee member, as applicable) of Brainstorm Cell Therapeutics on each vesting date."}],"balance_after":25333,"derivative":{"exercise_price":0.75,"exercise_date":"2020-01-12","expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":25333},"source":{"system":"sec-edgar","filing":"0001104659-20-021984","document":"tm205737d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920021984/tm205737d4_4.xml","form_type":"4"}},{"id":3426046,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-30T21:02:22.000Z","date":"2019-08-28","kind":"exercise","acquired":false,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested and became exercisable as to 33.3% of the number of shares subject to the option on each of August 31, 2010, August 31, 2011 and August 31, 2012."}],"balance_after":0,"derivative":{"exercise_price":2.25,"exercise_date":"2010-08-31","expiration_date":"2019-08-31","underlying":"Common Stock","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0001144204-19-043047","document":"tv528639_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420419043047/tv528639_4.xml","form_type":"4"}},{"id":3426045,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-30T21:02:22.000Z","date":"2019-08-28","kind":"exercise","acquired":false,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.25,"exercise_date":"2009-12-13","expiration_date":"2019-12-13","underlying":"Common Stock","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0001144204-19-043047","document":"tv528639_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420419043047/tv528639_4.xml","form_type":"4"}},{"id":3426044,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-30T21:02:22.000Z","date":"2019-08-28","kind":"sale","acquired":false,"shares":13332,"price":3.6672,"value":48891.1104,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":155833,"source":{"system":"sec-edgar","filing":"0001144204-19-043047","document":"tv528639_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420419043047/tv528639_4.xml","form_type":"4"}},{"id":3426043,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-30T21:02:22.000Z","date":"2019-08-28","kind":"exercise","acquired":true,"shares":6666,"price":2.25,"value":14998.5,"ownership":{"direct":true},"balance_after":169165,"source":{"system":"sec-edgar","filing":"0001144204-19-043047","document":"tv528639_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420419043047/tv528639_4.xml","form_type":"4"}},{"id":3426042,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-30T21:02:22.000Z","date":"2019-08-28","kind":"exercise","acquired":true,"shares":6666,"price":2.25,"value":14998.5,"ownership":{"direct":true},"balance_after":162499,"source":{"system":"sec-edgar","filing":"0001144204-19-043047","document":"tv528639_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420419043047/tv528639_4.xml","form_type":"4"}},{"id":3747799,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-11-30T22:04:44.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":25333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on December 30, 2018 until fully vested and exercisable on November 30, 2019, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date."}],"balance_after":25333,"derivative":{"exercise_price":0.75,"exercise_date":"2018-12-30","expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":25333},"source":{"system":"sec-edgar","filing":"0001144204-18-062653","document":"tv507903_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420418062653/tv507903_4.xml","form_type":"4"}},{"id":4165961,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-11-13T21:38:16.000Z","date":"2017-11-10","kind":"grant","acquired":true,"shares":25333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on December 10, 2017 until fully vested and exercisable on November 10, 2018, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date."}],"balance_after":25333,"derivative":{"exercise_price":0.75,"exercise_date":"2017-12-10","expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":25333},"source":{"system":"sec-edgar","filing":"0001144204-17-058401","document":"tv479020_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420417058401/tv479020_4.xml","form_type":"4"}},{"id":4220816,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-31T20:08:08.000Z","date":"2017-08-31","kind":"purchase","acquired":true,"shares":2500,"price":4.26,"value":10650.0,"ownership":{"direct":true},"balance_after":155833,"source":{"system":"sec-edgar","filing":"0001144204-17-046175","document":"v474446_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420417046175/v474446_4.xml","form_type":"4"}},{"id":4256546,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-17T21:01:01.000Z","date":"2017-07-13","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option is fully vested and exercisable on the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":0.75,"exercise_date":"2018-07-13","expiration_date":"2028-07-13","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001144204-17-037014","document":"v470752_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420417037014/v470752_4.xml","form_type":"4"}},{"id":4418276,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43248,"kind":"person","name":"ARBEL IRIT","position":1,"cik":"0001245607","reported_name":"ARBEL IRIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-28T22:18:44.000Z","date":"2017-02-26","kind":"grant","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option is fully vested and exercisable on the date of grant."}],"balance_after":6667,"derivative":{"exercise_price":0.75,"exercise_date":"2017-02-26","expiration_date":"2027-02-26","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001144204-17-011827","document":"v460623_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420417011827/v460623_4.xml","form_type":"4"}}]}